LifeStance Health GroupLFST -0.81%56 Days Sales Outstanding is 24.72 as of Mar. 2026, which is 30% below its 10-year median of 35.14. GuruFocus rates LFST with a GF Score™ of 56/100 and a GF Value™ of $8.27 (Modestly Overvalued). The stock has 5 warning signs investors should review. Among 656 Healthcare Providers & Services companies, LifeStance Health Group ranks better than 70.58% on this metric.
The historical rank and industry rank for LifeStance Health Group's Days Sales Outstanding or its related term are showing as below:
LFST'
s Days Sales Outstanding Range Over the Past 10 Years
Min: 29.15 Med: 35.14 Max: 39.12
Current: 29.77
During the past 7 years, LifeStance Health Group's highest Days Sales Outstanding was 39.12. The lowest was 29.15. And the median was 35.14.
LFST's Days Sales Outstanding is ranked better than 70.58% of 656
companies
in the Healthcare Providers & Services industry
Industry Median: 47.255
vs LFST: 29.77
LifeStance Health Group's Days Sales Outstanding
declined
from Mar. 2025 (37.29) to Mar. 2026 (24.72).
LifeStance Health Group (NAS:LFST) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
LifeStance Health Group Days Sales Outstanding Related Terms
LifeStance Health Group Days Sales Outstanding Historical Data
* Premium members only.
The historical data trend for LifeStance Health Group's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LifeStance Health Group Days Sales Outstanding Chart
LFST vs CON, BKD, OPCH: Days Sales Outstanding Comparison
For the Medical Care Facilities subindustry, LifeStance Health Group's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
LifeStance Health Group Days Sales Outstanding vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, LifeStance Health Group's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where LifeStance Health Group's Days Sales Outstanding falls into.
LifeStance Health Group Days Sales Outstanding Calculation
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LifeStance Health Group (LFST) has a Days Sales Outstanding of 24.72 as of Mar. 2026. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on LifeStance Health Group and its competitors. This is 30% below median its historical median of 35.14. Over the past decade, LifeStance Health Group's Days Sales Outstanding has ranged from 29.15 to 39.12. According to the industry distribution chart, LifeStance Health Group ranks #193 out of 656 companies in the Healthcare Providers & Services industry, placing it in the top 29.4%.
Is LifeStance Health Group's Days Sales Outstanding too high?
LifeStance Health Group's current Days Sales Outstanding of 24.72 is 30% below median its 10-year median of 35.14. Over the past 10 years, this metric has ranged from a low of 29.15 to a high of 39.12. The Healthcare Providers & Services industry median Days Sales Outstanding is 47.26. LifeStance Health Group's value of 24.72 is 47.7% below this industry median. Based on the distribution chart, LifeStance Health Group ranks #193 out of 656 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, LifeStance Health Group has a GF Score™ of 56/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does LifeStance Health Group's Days Sales Outstanding compare to CON and BKD?
According to the Healthcare Providers & Services industry distribution chart, LifeStance Health Group ranks #193 out of 656 companies for Days Sales Outstanding. This puts LifeStance Health Group in the upper half of its industry. The industry median Days Sales Outstanding is 47.26. LifeStance Health Group's value of 24.72 is 47.7% below this benchmark. Historically, LifeStance Health Group's own Days Sales Outstanding has ranged from 29.15 to 39.12 over the past decade. While the company's 10-year median is 35.14 vs. the industry median of 47.26, LifeStance Health Group has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Sales Outstanding for a Healthcare Providers & Services company?
The median Days Sales Outstanding among Healthcare Providers & Services companies is 47.26, based on 656 companies in the industry. Companies in the top quartile (top 25%) have a Days Sales Outstanding significantly above this median, while those in the bottom quartile fall well below. However, Days Sales Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. LifeStance Health Group's current Days Sales Outstanding of 24.72 is 47.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Sales Outstanding mean?
A high Days Sales Outstanding can signal that a stock is expensive relative to its fundamentals. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on LifeStance Health Group and its competitors. For the Healthcare Providers & Services industry, the median Days Sales Outstanding is 47.26 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. LifeStance Health Group's current Days Sales Outstanding is 24.72, which is 30% below median its own 10-year median of 35.14. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LifeStance Health Group stock overvalued right now?
Based on GuruFocus' analysis, LifeStance Health Group (LFST) is currently considered Modestly Overvalued. The stock's GF Value™ is $8.27, compared to a current price of $10.71 — trading 29.4% above its estimated fair value. The current Days Sales Outstanding is 24.72, which is 30% below median its 10-year median of 35.14 and 47.7% below the Healthcare Providers & Services industry median of 47.26. LifeStance Health Group's overall GF Score™ is 56/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Sales Outstanding calculated?
Days Sales Outstanding is calculated from a company's financial statements. For LifeStance Health Group (LFST), the current Days Sales Outstanding is 24.72 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is LifeStance Health Group (LFST) Overvalued in 2026?
Based on GuruFocus' analysis, LifeStance Health Group stock appears to be overvalued.
The current stock price of $10.71 is trading 29.4% above its estimated GF Value™ of $8.27.
GuruFocus considers LifeStance Health Group to be Modestly Overvalued.
Key valuation signals for LFST:
Days Sales Outstanding: 24.72 (30% below median its 10-year median of 35.14)
GF Value™: $8.27 vs. price of $10.71 (29.4% above fair value)
Industry Position: 47.7% below the Healthcare Providers & Services median (#193 of 656)
No single metric tells the full story. See the LFST stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
LifeStance Health Group Inc is a mental healthcare company that operates as a provider of outpatient mental health services, spanning psychiatric evaluations and treatment, psychological and neuropsychological testing, and individual, family, and group therapy. It treats a broad range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder, using evidence-based approaches to ensure effective treatment. The group has a single operating and reportable segment of mental health services.
56GF Score
Get the complete analysis for LFST
Days Sales Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LFST has been successfully added to your 
